close

Sun Pharma may incur revenue loss for ransomware incident on March 2

Sun Pharma Advanced Research Company may incur expenses in connection with incident; India was the second most attacked country for ransomware in the APAC-Japan region in 2022

Sohini Das Business Standard Mumbai
Sun Pharma
Premium

Listen to This Article

India’s largest drugmaker by market share, Sun Pharmaceutical Industries Ltd, has said that the IT security incident it faced earlier in March will impact the revenues of some of its businesses. The i
Or

Also Read

Sun Pharma Q2 PAT rises 10.5% YoY to Rs 2,262 crore on robust sales

Sun Pharma extends gains post September quarter earnings; up 6% in two days

WannaCry to SamSam: 5 biggest ransomware attacks you need to know about

Sun Pharma Q3 net profit up 5.2% as sales grow in India, US markets

We thrive on products that have limited competition: Top Sun Pharma execs

Mahindra firm, partner to set up mn sq ft warehouse park in Maharashtra

Bullish on Indian market, continuing to invest via partners: Coca-Cola

IT security incident to impact some of its businesses' revenues: Sun Pharma

HDFC board clears raising Rs 57,000 cr through non-convertible debentures

SoftBank-backed Oyo Hotels to reduce planned IPO amid tech headwinds

First Published: Mar 27 2023 | 7:04 PM IST

To read the full story, subscribe to BS Premium now, at just Rs 249/ month.

Key stories on business-standard.com are available only to BS Premium subscribers. Already a BS Premium subscriber?LOGIN NOW

Register to read more on Business-Standard.com